Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NORTHWEST-BIOTHERAPEUTICS-120787357/news/Northwest-Biotherapeutics-Reports-Positive-Top-Line-Results-from-Phase-3-Trial-of-DCVax-L-for-Glio-42352267/?utm_source=whatsapp&utm_medium=social&utm_campaign=share